Navigation Links
Veracyte, Inc. Announces Third Quarter 2013 Financial Results
Date:11/25/2013

  • Net loss for the third quarter of 2013 was $6.3 million, or $6.59 per common share, compared to a net loss of $4.9 million, or $7.49 per common share for the same period in 2012.
  • Conference Call DetailsVeracyte will host a live conference call and webcast today at 5 p.m. Eastern Time to discuss the company's financial results and provide a general business update. The live webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the company's website at least 15 minutes prior to the live webcast to ensure adequate time for any necessary software download. Alternatively, please call (855) 541-0980 (U.S.) or (970) 315-0440 (international) to listen to the live conference call. The conference ID number for the live call is 98673982. Please dial in approximately 10 minutes prior to the call. The webcast will be available on the company's website for 14 days approximately two hours following completion of the call.

    About Veracyte, Inc.Veracyte is focused on discovering, developing and commercializing molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient care, thus helping patients avoid unnecessary invasive procedures while reducing healthcare costs. Veracyte's first commercial solution, the Afirma Thyroid FNA Analysis, includes the Gene Expression Classifier (GEC). Over 525,000 fine needle aspiration (FNA) biopsies are performed each year in the United States on thyroid nodules suspicious for cancer, with up to 30% of FNAs yielding indeterminate results using cytopathology alone. Traditionally, most of these patients have undergone surgery to remove all or part of their thyroids, yet in 70% to 80% of cases, the nodules prove to be benign and thus the surgery was unnecessary. The GEC helps physicians reduce the number of unnecessary surgeries by employing a proprietary 1
    '/>"/>

    SOURCE Veracyte
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Veracyte, Inc. to Announce Third Quarter 2013 Financial Results and Host Conference Call on Monday, November 25, 2013
    2. Veracyte, Inc. Announces Pricing of Initial Public Offering
    3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
    4. Golden Meditech Announces 2013 / 2014 Interim Results
    5. iHealth Announces Results of AHA Walking Challenge
    6. Unilife Announces Results of 2013 Annual General Meeting
    7. Hanger Announces Appointment of Christopher B. Begley to Board of Directors
    8. CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013
    9. Array BioPharma Announces Management Team Change
    10. Hill-Rom Holdings, Inc. Announces First Quarter 2014 Dividend
    11. Argos Therapeutics Announces Additional $17.5 Million Of Series E Financing Bringing Total Commitment To $60 Million
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/17/2014)... -- Talyst, a market leader in pharmacy automation will be ... Nashville, TN. The company will be ... onsite, remote medication dispensing. Talyst,s InSite ... securely dispense medication onsite, on demand. Remote dispensing cuts ... the correct medication gets to the correct patient in ...
    (Date:10/17/2014)...   InnFocus, Inc ., reported on results of 59 ... for up to 3 years with the InnFocus MicroShunt® ... Chicago . The Summit ... of the American Academy of Ophthalmology . The Company ... patients in 6 countries by early 2015. Logo ...
    (Date:10/17/2014)... , Oct. 17, 2014  China Biologic Products, ... a leading fully integrated plasma-based biopharmaceutical company in ... the Company has received approval from the China ... manufacturing of human prothrombin complex concentrate ("PCC") at ... Taibang,s new coagulation factor production facility for Good ...
    Breaking Medicine Technology:Talyst Exhibits at LeadingAge Annual Meeting 2InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
    ... 14, 2011 mBeach Software Inc. ("MBHS") (MBHS.PK), the ... today that on Dec. 13, 2011 it entered into ... of IRIS Marketing Ltd., an Israeli company, that has ... facto merger of IRIS Marketing with mBeach, when concluded, ...
    ... Consumer Healthcare Products Association (CHPA) President and CEO Scott ... the 2011 National Institute on Drug Abuse,s (NIDA,s) Monitoring ... medicine abuse among twelfth graders has decreased by 1.2 ... tenth graders remained stable, at 2.7 and 5.5 percent ...
    Cached Medicine Technology:mBeach Software Inc. to Acquire a Controlling Interest in IRIS Marketing Ltd. 2Statement from the Consumer Healthcare Products Association (CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2
    (Date:10/20/2014)... Dunbridge, Ohio (PRWEB) October 20, 2014 ... 50 years, takes pride in manufacturing top-of-the-line absorbent products. ... the image of its most popular brand, Tranquility® Premium ... logo, created a new website, gave its packaging a ... to bring the brand message to the public. , ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
    (Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
    (Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
    (Date:10/19/2014)... October 19, 2014 Dr. Babatunde Osotimehin, ... welcomes news of a ceasefire agreement that is expected ... 200 girls who were kidnapped from the north-eastern Nigerian ... in captivity long enough, and it is high time ... stated Dr. Osotimehin. , "We owe it to these ...
    Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
    ... condition of VHP leader Praveen Togadiya, who underwent an angioplasty ... hospital sources said today. // ,Togadiya was admitted ... ,Cardiologist of the Hospital Dr Bhupesh Shah carried out the ... at the hospital, the condition of the leader is stable ...
    ... new study, researchers from the Cornell University in the ... Study //of Youth in 1979, to analyze the correlation ... causes of death – smoking and obesity. Their ... forthcoming July issue of the Journal of Labor Economics, ...
    ... is common among Africans as a custom rather than as ... way of curbing sexual waywardness //in the females while some ... as a method of initiating teenage girls into adulthood. ... knives, blades and scissors which are often unsterilized. In addition ...
    ... are sleeping less than 5-6 hours a night, which could ... chronic illnesses//. ,The survey was conducted by scientists ... residents and found that about one in five persons suffered ... suffered from chronic daytime sleepiness while more than 30 per ...
    ... at the Lawrence Livermore Berkeley National Library revealed that the DNA ... and the effects of dwarfism begins to take its toll. The ... ago, over a four-month period, .from 97 healthy men between the ... was employed to ‘sort’ out the sperms for this study. ...
    ... has ruled out human-to-human transmission of bird flu in ... the disease // , easing fears that the virus ... among humans. ,'The negative test results for all ... not spreading efficiently or sustainably among humans at present,' ...
    Cached Medicine News:Health News:Female Circumcision Rampant in Africa 2
    ... is a modular orthotic elbow system that can ... distal humeral fractures, proximal ulnar fractures or post ... K2 is a highly flexible system that provides ... assemble the brace that best fits your patients ...
    The IROM Elbow is ideal for fixed or controlled ROM in the treatment of stable supracondylar fractures, stable radial fractures, and lateral/medial epicondylitis....
    A lightweight soft good with rigid elbow protection. Designed by medical professionals with your needs in mind. Provides elbow stability for mild to moderate medial/lateral and hyperextension injurie...
    Innovative support that immobilizes and positions elbow at 122 to minimize stretching of ulnar nerve...
    Medicine Products: